Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Long-Term Deferred Tax (2016 - 2017)

Wave Life Sciences' Long-Term Deferred Tax history spans 3 years, with the latest figure at $774000.0 for Q2 2017.

  • For Q2 2017, Long-Term Deferred Tax rose 303.12% year-over-year to $774000.0; the TTM value through Jun 2017 reached $774000.0, up 303.12%, while the annual FY2016 figure was $560000.0, 191.67% up from the prior year.
  • Long-Term Deferred Tax reached $774000.0 in Q2 2017 per WVE's latest filing, roughly flat from $774000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $774000.0 in Q1 2017 to a low of $32000.0 in Q3 2016.
  • Average Long-Term Deferred Tax over 3 years is $388000.0, with a median of $192000.0 recorded in 2015.
  • Peak YoY movement for Long-Term Deferred Tax: skyrocketed 191.67% in 2016, then soared 303.12% in 2017.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $192000.0 in 2015, then skyrocketed by 191.67% to $560000.0 in 2016, then skyrocketed by 38.21% to $774000.0 in 2017.
  • Per Business Quant, the three most recent readings for WVE's Long-Term Deferred Tax are $774000.0 (Q2 2017), $774000.0 (Q1 2017), and $560000.0 (Q4 2016).